Synthetic Cannabinoid Exposure

Abstract

Get full access to this article

View all access options for this article.

References

Wiebelhaus

Poklis

Vann

Lichtman

Wise

LE.

Inhalation exposure to smoke from synthetic ‘marijuana’ produces potent canabimimetic effects in mice. Drug Alcohol Depend. 2012;126:316-323.

McCarberg

Barkin

RL.

The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview. Am J Ther. 2007;14:475-483.

Debruyne

Le Boisselier

Emerging drugs of abuse: current perspectives on synthetic cannabinoids. Subst Abuse Rehabil. 2015;6:113-129.

The Synthetic Drug Abuse Prevention Act of 2012. February 12, 2016. https://www.gpo.gov/fdsys/pkg/BILLS-112s3190is/pdf/BILLS-112s3190is.pdf. Accessed July 26, 2016.

Spaderna

Addy

D’Souza

DC.

Spicing things up: synthetic cannabinoids. Psychopharmacology (Berl). 2013;228:525-540.

Castaneto

Gorelick

Desrosiers

Hartman

Pirard

Huestis

MA.

Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend. 2014;144:12-41.

Buser

Gerona

Horowitz

. Acute kidney injury associated with smoking synthetic cannabinoid. Clin Toxicol (Phila). 2014;52:664-673.

Clark

Georgekutty

Berul

CI.

Myocardial ischemia secondary to synthetic cannabinoid (K2) use in pediatric patients. J Pediatr. 2015;167:757-761.

Lapoint

James

Moran

Nelson

Hoffman

Moran

JH.

Severe toxicity following synthetic cannabinoid ingestion. Clin Toxicol (Phila). 2011;49:760-764.

10.

Mir

Obafemi

Young

Kane

Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics. 2011;128:e1622-e1627.

11.

Centers for Disease Control and Prevention. Acute kidney injury associated with synthetic cannabinoid use—multiple states, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(6):93-98.

12.

Rosenbaum

Carreiro

Babu

KM.

Here today and gone tomorrow . . . and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol. 2012;8:15-32.

13.

Woo

Hanley

JR.

“How high do they look?” Identification and treatment of common ingestions in adolescents. J Pediatr Health Care. 2013;27:135-144.